Загрузка...
Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines
BACKGROUND & AIMS: It is estimated that 3.26 million children and adolescents worldwide have chronic HCV infection. To date, the global response has focused on the adult population, but direct-acting antiviral (DAA) regimens are now approved for children aged ≥3 years. This global review describ...
Сохранить в:
| Опубликовано в: : | JHEP Rep |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7898178/ https://ncbi.nlm.nih.gov/pubmed/33665586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2021.100227 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|